Employees Retirement System of Texas’s Recursion Pharmaceuticals RXRX Stock Holding History

Employees Retirement System of Texas’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Hold	44,679	–	–	﹤0.01%	365
2026 Q1	$137K	Hold	44,679	–	–	﹤0.01%	353
2025 Q4	$183K	Hold	44,679	–	–	﹤0.01%	344
2025 Q3	$218K	Hold	44,679	–	–	﹤0.01%	322
2025 Q2	$226K	Hold	44,679	–	–	﹤0.01%	355
2025 Q1	$236K	Hold	44,679	–	–	﹤0.01%	249
2024 Q4	$302K	Hold	44,679	–	–	﹤0.01%	287
2024 Q3	$294K	Sell	44,679 -5,672	-11%	-$40.7K	﹤0.01%	311
2024 Q2	$378K	Buy	50,351 +5,953	+13%	+$51.9K	﹤0.01%	287
2024 Q1	$443K	Buy	44,398 +22,000	+98%	+$245K	﹤0.01%	296
2023 Q4	$221K	Buy	+22,398	New	+$160K	﹤0.01%	320

Other funds holding RXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Employees Retirement System of Texas's RXRX Position: Q2 2026 in Review

Employees Retirement System of Texas held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 44,679 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Employees Retirement System of Texas first reported a position in RXRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $443K in Q1 2024. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

Employees Retirement System of Texas held 44,679 shares of Recursion Pharmaceuticals worth $164K as of Q2 2026.
Employees Retirement System of Texas left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
Recursion Pharmaceuticals made up ﹤0.01% of Employees Retirement System of Texas's portfolio in Q2 2026, its #365 holding.
Employees Retirement System of Texas first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Employees Retirement System of Texas's Recursion Pharmaceuticals position peaked at $443K in Q1 2024.
343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.